Ventilator-Associated Pneumonia Due to MRSA vs. MSSA: What Should Guide Empiric Therapy?

• Main Authors: Marta Colaneri (Author), Domenico Di Carlo (Author), Alessandro Amatu (Author), Lea Nadia Marvulli (Author), Marta Corbella (Author), Greta Petazzoni (Author), Patrizia Cambieri (Author), Alba Muzzi (Author), Claudio Bandi (Author), Angela Di Matteo (Author), Paolo Sacchi (Author), Francesco Mojoli (Author), Raffaele Bruno (Author)
• Format: Book
• Published: MDPI AG, 2022-06-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

The guidelines on ventilator-associated pneumonia (VAP) recommend an empiric therapy against methicillin-resistant <i>Staphylococcus aureus</i> (MRSA) according to its prevalence rate. Considering the MRSA and MSSA VAP prevalence over the last 9 years in our tertiary care hospital, we as...